BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

437 related articles for article (PubMed ID: 10460635)

  • 41. Laparoscopic liver resection.
    Vibert E; Perniceni T; Levard H; Denet C; Shahri NK; Gayet B
    Br J Surg; 2006 Jan; 93(1):67-72. PubMed ID: 16273531
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Autologous blood storage before hepatectomy for hepatocellular carcinoma.
    Kato K; Nomoto S; Sugimoto H; Kanazumi N; Takeda S; Nakao A
    Hepatogastroenterology; 2009; 56(91-92):802-7. PubMed ID: 19621706
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Perioperative use of the LiMON method of indocyanine green elimination measurement for the prediction and early detection of post-hepatectomy liver failure.
    de Liguori Carino N; O'Reilly DA; Dajani K; Ghaneh P; Poston GJ; Wu AV
    Eur J Surg Oncol; 2009 Sep; 35(9):957-62. PubMed ID: 19250796
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Resection of hepatocellular carcinoma: the effect of surgical margin and blood transfusion on long-term survival. Analysis of 209 consecutive patients.
    Tralhão JG; Kayal S; Dagher I; Sanhueza M; Vons C; Franco D
    Hepatogastroenterology; 2007 Jun; 54(76):1200-6. PubMed ID: 17629070
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Factors for prolonged length of stay after elective hepatectomy for hepatocellular carcinoma. The surgeon's role in the managed care era.
    Hsia CY; Chau GY; King KL; Loong CC; Lui WY; Wu CW
    Hepatogastroenterology; 2003; 50(51):798-804. PubMed ID: 12828088
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Influence of laparoscopy on postoperative recurrence and survival in patients with ruptured hepatocellular carcinoma undergoing hepatic resection.
    Lang BH; Poon RT; Fan ST; Wong J
    Br J Surg; 2004 Apr; 91(4):444-9. PubMed ID: 15048744
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Duration of hepatic vascular inflow clamping and survival after liver resection for hepatocellular carcinoma.
    Ishizuka M; Kubota K; Kita J; Shimoda M; Kato M; Sawada T
    Br J Surg; 2011 Sep; 98(9):1284-90. PubMed ID: 21633950
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Longterm prognosis after hepatic resection for small hepatocellular carcinoma.
    Shimozawa N; Hanazaki K
    J Am Coll Surg; 2004 Mar; 198(3):356-65. PubMed ID: 14992736
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Anterior approach versus conventional approach right hepatic resection for large hepatocellular carcinoma: a prospective randomized controlled study.
    Liu CL; Fan ST; Cheung ST; Lo CM; Ng IO; Wong J
    Ann Surg; 2006 Aug; 244(2):194-203. PubMed ID: 16858181
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prognostic factors and survival after hepatic resection for hepatocellular carcinoma without cirrhosis.
    Nagasue N; Ono T; Yamanoi A; Kohno H; El-Assal ON; Taniura H; Uchida M
    Br J Surg; 2001 Apr; 88(4):515-22. PubMed ID: 11298618
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Indocyanine green clearance test and model for end-stage liver disease score of patients with liver cirrhosis.
    Sheng QS; Lang R; He Q; Yang YJ; Zhao DF; Chen DZ
    Hepatobiliary Pancreat Dis Int; 2009 Feb; 8(1):46-9. PubMed ID: 19208514
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Systematic hepatectomy for small hepatocellular carcinoma in Korea.
    Suh KS
    J Hepatobiliary Pancreat Surg; 2005; 12(5):365-70. PubMed ID: 16258804
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Management of spontaneous bleeding due to hepatocellular carcinoma.
    Recordare A; Bonariol L; Caratozzolo E; Callegari F; Bruno G; Di Paola F; Bassi N
    Minerva Chir; 2002 Jun; 57(3):347-56. PubMed ID: 12029230
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Model for End-stage Liver Disease score fails to predict perioperative outcome after hepatic resection for hepatocellular carcinoma in patients without cirrhosis.
    Teh SH; Sheppard BC; Schwartz J; Orloff SL
    Am J Surg; 2008 May; 195(5):697-701. PubMed ID: 18367132
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Predicting immunosuppressant dosing in the early postoperative period with noninvasive indocyanine green elimination following orthotopic liver transplantation.
    Parker BM; Cywinski JB; Alster JM; Irefin SA; Popovich M; Beven M; Fung JJ
    Liver Transpl; 2008 Jan; 14(1):46-52. PubMed ID: 18161838
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Intraoperative iatrogenic rupture of hepatocellular carcinoma.
    Liu CL; Fan ST; Lo CM; Ng IO; Poon RT; Wong J
    World J Surg; 2002 Mar; 26(3):348-52. PubMed ID: 11865373
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Long-term effect of united hepatectomy and splenectomy on treatment of hepatocellular carcinoma complicated with cirrhosis and hypersplenism].
    Cai JQ; Hu JQ; Bi XY; Zhao JJ; Che X; Xie SL; Shao YF; Zhao P
    Zhonghua Yi Xue Za Zhi; 2004 Jan; 84(1):6-8. PubMed ID: 14990147
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Resection of segment VIII for hepatocellular carcinoma.
    Kishi Y; Hasegawa K; Kaneko J; Aoki T; Beck Y; Sugawara Y; Makuuchi M; Kokudo N
    Br J Surg; 2012 Aug; 99(8):1105-12. PubMed ID: 22696436
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hepatectomy and marked retention of indocyanine green and bromosulfophtalein.
    Yamanaka N; Shimizu S; Chijiiwa K; Nishiyama K; Noshiro H; Yamaguchi K; Tanaka M
    Hepatogastroenterology; 2001; 48(41):1450-2. PubMed ID: 11677984
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Predictive value of indocyanine green retention rate with respect to complications of radiofrequency ablation in 878 patients with hepatocellular carcinoma.
    Tang T; Feng X; Yan J; Xia F; Li X; Ma K; Bie P
    Int J Hyperthermia; 2014 Sep; 30(6):402-7. PubMed ID: 25256893
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.